ArticleInternational journal of women's health2026
The Health and Productivity Impact of Thyroid Diseases Among Working-Age Women in Western Europe.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypothyroidism and hyperthyroidism are common but clinically distinct disorders that can impair work through fatigue, cognitive slowing, mood symptoms, weakness, palpitations, and heat intolerance. We quantified the health and formal-labor-market productivity burden of the combined Global Burden of Disease (GBD) thyroid-diseases category among working-age women in Western Europe. Methods: Historical epidemiological estimates for women aged 20-64 years in 24 Western European countries were obtained from GBD 2023 for 1990-2023. Joinpoint regression and locally weighted smoothing characterized temporal and sociodemographic patterns. A Bayesian age-period-cohort model based on the 1990-2023 series projected years lived with disability and years of life lost for 2024-2029; the 2023 estimate was retained as the baseline. Projected health loss was translated into productivity-adjusted life-years and discounted gross domestic product losses using a Bayesian productivity-adjusted life-year framework. Results: In 2023, the age-standardized disability-adjusted life-year rate ranged from 56.26 per 100,000 women in Spain (95% uncertainty interval, 29.22-96.78) to 107.71 in Norway (55.61-187.94). The regional rate changed little during 1990-2023 (average annual percent change, -0.06%) but followed six distinct temporal segments. Annual years lived with disability were projected to decline from 108.07 thousand (95% credible interval, 107.18-108.96) in 2023 to 102.55 thousand (90.44-114.66) in 2029, whereas years of life lost were projected to increase from 5.40 thousand (5.21-5.59) to 6.13 thousand (3.68-8.58). Across 2023-2029, cumulative productivity loss was 127.48 thousand productivity-adjusted life-years (112.70-142.26), equivalent to Int$8.23 billion in discounted gross domestic product (7.27-9.18). Conclusion: The combined noncancer thyroid-diseases category produces a persistent disability-dominated burden and substantial estimated losses in formal-market productivity among working-age women in Western Europe. The estimates should not be interpreted as subtype-specific or as including unpaid, caregiving, informal-sector, or thyroid-cancer-related losses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.